Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Pfizer Inc. (PFE) vs Sanofi (SNY)

Pfizer Inc. and Sanofi are both Drug Manufacturers General companies. Pfizer Inc. is the larger, with a market value of $161.7B against $97.4B — 1.7× the size. Sanofi trades at the lower P/E: 21.5× against 37.7×. Sanofi grew revenue faster over the last twelve months: 21.3% against −0.21%. Sanofi has the higher net margin (8.22% vs 6.80%) and the higher return on invested capital (6.58% vs 6.30%). Both pay a dividend; Pfizer Inc. yields more (6.18% vs 4.40%). Across the 23 metrics below, Sanofi leads on 16 and Pfizer Inc. on 7.

Valuation

Metric PFE SNY Drug Manufacturers General median
P/E 37.71 21.52 24.72
P/S 2.56 1.73 3.35
P/B 1.91 1.22 5.00
Price to free cash flow 16.04 6.77 17.68
EV/EBITDA 10.53 11.19 13.91
EV/Sales 3.37 2.04 3.95
Earnings yield 2.65% 4.65% 2.92%
Free cash flow yield 6.24% 14.78% 4.42%

Profitability

Metric PFE SNY Drug Manufacturers General median
Gross margin 73.18% 72.78% 72.77%
Operating margin 21.70% 18.24% 18.90%
Net margin 6.80% 8.22% 8.27%
Free cash flow margin 17.25% 25.53% 17.25%
Return on equity 4.97% 5.87% 6.97%
Return on assets 2.13% 3.21% 2.76%
Return on invested capital 6.30% 6.58% 6.30%

Growth

Metric PFE SNY Drug Manufacturers General median
Revenue growth (TTM) (0.21%) 21.30% 6.79%
EPS growth (last fiscal year) (3.55%) 45.97% —
Revenue growth, 5-year CAGR 8.48% 4.37% 3.98%
Net income growth, 5-year CAGR (3.23%) (8.87%) 0.42%

Health

Metric PFE SNY Drug Manufacturers General median
Debt to equity 0.74 0.31 0.63
Current ratio 1.27 0.99 1.32
Net debt to EBITDA 2.46 0.76 1.15

Dividend

Metric PFE SNY Drug Manufacturers General median
Dividend yield 6.18% 4.40% 3.57%
Payout ratio 0.43 0.52 0.53

Size

Metric PFE SNY Drug Manufacturers General median
Market cap 161.70b 97.44b 125.91b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack